Hap Trading, LLC Otonomy, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$1.72 - $2.51 $88,580 - $129,264	-51,500 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.72 - $2.47 $52,804 - $75,829	30,700 Added 147.6%	51,500 $21,000
Q4 2021 Feb 14, 2022	BUY	$1.69 - $2.31 $35,152 - $48,048	20,800 New	20,800 $2,000
Q1 2021 May 14, 2021	SELL	$2.49 - $6.23 $31,374 - $78,498	-12,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.47 $43,848 - $81,522	12,600 New	12,600 $30,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.